A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients

Prognostic and predictive markers are needed to predict the clinical outcomes of patients with advanced colorectal cancer (CRC) who receive standard first-line treatments. We performed a prospective cohort study in advanced CRC patients to identify a miRNA signature that could predict the benefit of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jia-huan, Zuo, Zhi-xiang, Wang, Wei, Zhao, Qi, Qiu, Miao-zhen, Luo, Hui-yan, Chen, Zhan-hong, Mo, Hai-yu, Wang, Feng, Yang, Dong-dong, Wang, Yun, Wei, Xiao-li, Wu, Qi-nian, Ju, Huai-qiang, Xu, Rui-hua, Zeng, Zhao-lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299080/
https://www.ncbi.nlm.nih.gov/pubmed/30588338
http://dx.doi.org/10.1038/s41420-018-0133-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299080/
https://www.ncbi.nlm.nih.gov/pubmed/30588338
http://dx.doi.org/10.1038/s41420-018-0133-7

Ejemplares similares